On one hand, the genome wide association studies (GWAS) have identified variants in the genes PNPLA3, TM6SF2, GCKR, MBOAT7, and HSD17B13 that seem to be associated with susceptibility to and/or progression of NAFLD [6]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.